GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (STU:72X) » Definitions » Ending Cash Position

MicroPort CardioFlow Medtech (STU:72X) Ending Cash Position : €14.17 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Ending Cash Position?

MicroPort CardioFlow Medtech's Ending Cash Position for the quarter that ended in Dec. 2024 was €14.17 Mil.

MicroPort CardioFlow Medtech's quarterly Ending Cash Position declined from Dec. 2023 (€136.79 Mil) to Jun. 2024 (€102.58 Mil) and declined from Jun. 2024 (€102.58 Mil) to Dec. 2024 (€14.17 Mil).

MicroPort CardioFlow Medtech's annual Ending Cash Position declined from Dec. 2022 (€252.71 Mil) to Dec. 2023 (€136.79 Mil) and declined from Dec. 2023 (€136.79 Mil) to Dec. 2024 (€14.17 Mil).


MicroPort CardioFlow Medtech Ending Cash Position Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Ending Cash Position Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 76.99 307.29 252.71 136.79 14.17

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 252.71 135.67 136.79 102.58 14.17

MicroPort CardioFlow Medtech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

MicroPort CardioFlow Medtech's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=139.705+-125.535
=14.17

MicroPort CardioFlow Medtech's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=105.079+-90.909
=14.17


MicroPort CardioFlow Medtech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

MicroPort CardioFlow Medtech Headlines

No Headlines